Evaluation of a Cocooning Program on Infant Pertussis Infection in the Northern Territory

Kristen Overton; Rosalind Webby; Peter Markey; Vicki Krause

doi:10.1055/s-0037-1616859

Journal of Pediatric Infectious Diseases, Table of Contents

J Pediatr Infect Dis 2018; 13(01): 070-074
DOI: 10.1055/s-0037-1616859

Original Article

Georg Thieme Verlag KG Stuttgart · New York

Evaluation of a Cocooning Program on Infant Pertussis Infection in the Northern Territory

Kristen Overton

¹Northern Territory Centre of Disease Control, Darwin, Northern Territory, Australia

²Royal Darwin Hospital, Tiwi, Northern Territory, Australia

³University of New South Wales, Medical School, Sydney, New South Wales, Australia

,

Rosalind Webby

¹Northern Territory Centre of Disease Control, Darwin, Northern Territory, Australia

,

Peter Markey

¹Northern Territory Centre of Disease Control, Darwin, Northern Territory, Australia

,

Vicki Krause

¹Northern Territory Centre of Disease Control, Darwin, Northern Territory, Australia

› Author Affiliations

Abstract

Since 2008, the Northern Territory (NT) Guidelines recommended delivering dTpa vaccine to postnatal women and all other household and close infant contacts. We aim to determine whether this pertussis cocooning strategy reduced infections in young infants in the NT. Infants < 12 months of age notified with pertussis and born at times when the cocooning strategy was in place (2009–2014) were compared with infants born preintervention (2002–2007). The proportion of cases of pertussis occurring in infants < 12 months of age was significantly higher in the preintervention period (6.7%) compared with the cocooning period (3.3%, p = 0.0067).

Keywords

pertussis - vaccination - cocooning

Full Text

References

References
1 Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005; 24 (5, Suppl): S62-S65
2 Australian Technical Advisory Group on Immunisation (ATAGI). The Australian Immunisation Handbook. 10th ed. (2017 update). Canberra: Australian Government Department of Health; 2017
3 Bisgard KM, Pascual FB, Ehresmann KR. , et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004; 23 (11) 985-989
4 Zepp F, Heininger U, Mertsola J. , et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11 (07) 557-570
5 Rodríguez-Cobo I, Chen YF, Olowokure B, Litchfield I. Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: a systematic review. Vaccine 2008; 26 (52) 6768-6776
6 Centre for Disease Control. NT Immunisation Schedule. Darwin: Department of Health Northern Territory; 2008
7 de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology 2012; 23 (06) 852-860
8 Wendelboe AM, Njamkepo E, Bourillon A. , et al; Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26 (04) 293-299
9 Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22 (23–24): 3154-3165
10 Coudeville L, Van Rie A, Getsios D, Caro JJ, Crépey P, Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One 2009; 4 (07) e6284 doi: 10.1371/journal.pone.0006284
11 Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics 2008; 122 (03) e550-e555
12 Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011; 52 (02) 157-162
13 Walter EB, Allred N, Rowe-West B, Chmielewski K, Kretsinger K, Dolor RJ. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr 2009; 9 (05) 344-347
14 Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics 2014; 134 (04) 713-720
15 Healy CM, Rench MA, Wootton SH, Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J 2015; 34 (01) 22-26
16 Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012; 54 (01) 78-84
17 Hall R. . Notifiable diseases surveillance 1917–1991. The Department of Health. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-oz_dis19_91.htm/$FILE/ozdis1917_91.pdf . Accessed May 31, 2017
18 The Department of Health. Pertussis - CDNA national guidelines for public health units. Updated April 2015. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-pertussis.htm . Accessed May 31, 2017
19 Centre for Disease Control. Manual for the public health management of notifiable diseases in the Northern Territory. Darwin: Department of Health Northern Territory; 2016
20 The Department of Health. Communicable Disease Network of Australia (CDNA) Pertussis case definition. Updated January 2014 Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_pertus.htm . Accessed May 31, 2017
21 Australian Bureau of Statistics. TABLE 57. Estimated Resident Population by Single Year of Age, Northern Territory. Available at: http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Dec%202015?OpenDocument . Accessed May 31, 2017
22 Carcione D, Regan AK, Tracey L. , et al. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine 2015; 33 (42) 5654-5661